Artemis Therapeutics (OTCMKTS:ATMS) & ARQ (NASDAQ:ARQ) Head-To-Head Review

Artemis Therapeutics (OTCMKTS:ATMS) and ARQ (NASDAQ:ARQ) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Insider & Institutional Ownership

18.5% of ARQ shares are owned by institutional investors. 7.5% of Artemis Therapeutics shares are owned by insiders. Comparatively, 22.2% of ARQ shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Artemis Therapeutics and ARQ’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Artemis Therapeutics	-299.54%	N/A	-425.51%
ARQ	-8.15%	-4.65%	-3.51%

Analyst Ratings

This is a breakdown of recent recommendations for Artemis Therapeutics and ARQ, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artemis Therapeutics	0	0	0	0	N/A
ARQ	0	0	0	0	N/A

Risk and Volatility

Artemis Therapeutics has a beta of -1.92, indicating that its stock price is 292% less volatile than the S&P 500. Comparatively, ARQ has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500.

Valuation and Earnings

This table compares Artemis Therapeutics and ARQ’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artemis Therapeutics	$310,000.00	0.76	-$1.36 million	N/A	N/A
ARQ	$99.18 million	2.33	-$12.25 million	($0.27)	-23.78

Artemis Therapeutics has higher earnings, but lower revenue than ARQ.

Summary

ARQ beats Artemis Therapeutics on 7 of the 9 factors compared between the two stocks.

About Artemis Therapeutics

Artemis Therapeutics, Inc. is a biopharmaceutical company. It develops new treatments for serious and life-threatening infections. It Includes cytomegalovirus and malaria. The company was founded on April 22, 1997 and was headquartered in New York, NY.

About ARQ

Arq, Inc. produces activated carbon products in North America. The company's products include granular activated carbon, powdered and granular activated carbon, and colloidal carbon products; Arq Powder Wetcake, a fine and low-ash coal waste-derived particle; and additives for air emissions control. Its products are used in various applications, including water treatment, ground water remediation, soil sediments, air emissions, and asphalt additives. The company was formerly known as Advanced Emissions Solutions, Inc. and changed its name to Arq, Inc. in February 2024. Arq, Inc. was founded in 1997 and is headquartered in Greenwood Village, Colorado.